NL-OMON34745
Not yet recruiting
Not Applicable
An Assessment of the Prevalence of Psoriasis in Patients with Hepatitis C - An Assessment of the Prevalence of Psoriasis in Patients with Hepatitis C
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- chronic skin disease with increased keratinization
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 80
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Age 18 years or greater
- •2\.Subjects must have a previous diagnosis of Hepatitis C. This would include all patients with a positive serology for Hepatitis C.
- •3\.Patients in the treatment group should be treated for at least one dose, within the last 6 months, with pegylated interferon\-\*.
Exclusion Criteria
- •1\.Subjects younger than 18 years old
- •2\.Subjects with any skin disease, disease state, or physical condition that would impair evaluation of the skin, for example not able to undress or stand up.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Frequency of arthritis in patients of psoriasisHealth Condition 1: L405- Arthropathic psoriasisCTRI/2020/02/023523Maulana Azad Medical College
Recruiting
Not Applicable
Evaluation of knowledge, attitude and practice about psoriasis disease and its management among psoriasis patientsHealth Condition 1: L405- Arthropathic psoriasisHealth Condition 2: L401- Generalized pustular psoriasisHealth Condition 3: L404- Guttate psoriasisHealth Condition 4: L408- Other psoriasisHealth Condition 5: L400- Psoriasis vulgarisHealth Condition 6: L409- Psoriasis, unspecifiedHealth Condition 7: L403- Pustulosis palmaris et plantarisCTRI/2021/12/038550Dr Braj Bhushan Kumar
Completed
Not Applicable
Association between Psoriasis and gum diseasesHealth Condition 1: L400- Psoriasis vulgarisCTRI/2018/04/013475DEPARTMENT OF SCIENCE AND TECHNOLOGY CHANDIGARH84
Completed
Not Applicable
Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK RegistryPsoriatic ArthritisPsoriasisNCT06172426Novartis Pharmaceuticals1,171
Active, not recruiting
Not Applicable
Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of CarePsoriasisNCT04780516AbbVie141